Document is current

Article History

Received: 5 February 2020

Accepted: 25 August 2020

First Online: 5 September 2020

Ethics approval and consent to participate

: Continuous visits to the diabetes clinic are part of the standard treatment for diabetes patients and are prioritized in the guidelines from the National Board of Health and Welfare. The study will not generate any additional visits and is not associated with any known additional risks. Furthermore, the questionnaires used in the study have been validated in previous studies and do not contain any questions that are considered to violate or threaten personal integrity. Written informed consent will be obtained from all participants prior to inclusion in the study. Participants can withdraw from the trial at any time without providing reasons. All material is coded with consecutive digit code. All personal information will be managed in accordance with the General Data Protection Regulation (GDPR).All forms, questionnaires and tapes related to study data will be kept in locked cabinets. Access to the study data will be restricted. The code list is stored in a locked fireproof cabinet.The Ethical Review Board in Uppsala with file number 2018–568, Sweden (Etikprövningsmyndigheten, Uppsala Sweden) has approved this study (Dnr: 2019–00133). Further, the clinical trial has been registered at ISRCTN number: 73435627; ExternalRef removed .

: Not applicable.

: All authors declare no competing interests.